RobertAndrewGilbertMD

Radiation Oncology • Mobile, AL

Radiation Oncologist, delivering cutting-edge technology and treatment for cancer patients.

Join to view full profile

Dr. Gilbert is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gilbert's full profile

Already have an account?

Office
1660 Springhill Ave.
Mobile, AL 36604
Phone+1 251-410-1010

Fax+1 251-445-8363

Summary

Dr. Robert A. Gilbert is a Radiation Oncologist, delivering cutting-edge technology and treatment for cancer patients. He completed a Research Fellowship at Baylor College of Medicine in Houston, TX. He is an Assistant Professor of Interdisciplinary Clinical Oncology at the USA College of Medicine.

Robert Gilbert, M.D. | USA Health

A Phase 3 Study of Pembrolizumab (MK-3475) in Combination with Concurrent Chemoradiation Therapy Followed by Pembrolizumab with or without Olaparib vs Concurren

Education & Training

Baylor College of MedicineResidency, Radiation Oncology, 1991 - 1994
Baylor College of MedicineInternship, Internal Medicine, 1990 - 1991
Baylor College of MedicineClass of 1990

Certifications & Licensure

AL State Medical License 1995 - 2025
TX State Medical License 1991 - 2024
GA State Medical License 2012 - 2020
FL State Medical License 1996 - 2016
OK State Medical License 2013 - 2016
American Board of Radiology Radiation Oncology

Clinical Trials

Hypo-Hyperfractionated Chest Radiation for Non Small Cell Lung Cancer With Taxotere/Xeloda Combination Chemotherapy Start of enrollment: 2005 Sep 01
Withdrawn
Phase 1, Phase 2
Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer Start of enrollment: 2008 Jun 01
Completed
Phase 3
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
Completed
Phase 3
Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer Start of enrollment: 2012 Feb 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

2 citations
The adherence to the American Association for the Study of Liver Diseases 2018 guidelines in the management of hepatocellular carcinoma and its impact on survival.
Ashish Manne, Madhuri Mulekar, Daisy Escobar, Pranitha Prodduturvar, Yazan Fahmawi
Journal of Cancer Research and Therapeutics. 2023-10-03
9 citations
Clinical and Hematological Predictors of High-Grade Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors
Ashish Manne, Madhuri S. Mulekar, Daisy E Escobar, Alhareth Alsayed, Gaurav Sharma
Journal of Clinical Medicine Research. 2021-05-25

Press Mentions

Mitchell Cancer Institute Launches New Radiation Technology for PatientsMay 10th, 2023